Mariner, LLC

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1373442 Overland Park, KS

Position in SRPT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,226,878

-$2,554,294 QoQ

Shares Held

123,922

-43.6% QoQ

Ownership

0.117%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#79

of 323 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Mariner, LLC holds $491,869,472 across 152 Biotechnology names. SRPT ranks #22 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	608,615	$146,657,956
2	VRTX	Vertex Pharmaceuticals Inc / Ma	134,614	$66,866,811
3	REGN	Regeneron Pharmaceuticals, Inc.	100,086	$62,407,624
4	RPRX	Royalty Pharma plc	693,495	$38,884,263
5	EXEL	Exelixis, Inc.	313,083	$17,034,845
6	INCY	Incyte Corp	121,988	$13,828,559
7	BMRN	Biomarin Pharmaceutical Inc	192,607	$11,020,972
8	ALNY	Alnylam Pharmaceuticals, Inc.	28,021	$8,435,161

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,226,878	123,922	-43.6%	Shares	Sole	2026-08-13
2026-03-31	$4,781,172	219,723	-14.5%	Shares	Sole	2026-05-13
2025-12-31	$5,532,555	257,089	+373.5%	Shares	Sole	2026-02-13
2025-09-30	$1,046,168	54,290	+627.8%	Shares	Sole	2025-11-14
2025-03-31	$476,033	7,459	-7.2%	Shares	Sole	2025-05-15
2024-12-31	$977,826	8,042	+14.8%	Shares	Sole	2025-02-13
2024-09-30	$875,104	7,007	+2.4%	Shares	Sole	2024-11-13
2024-06-30	$1,081,352	6,844	+9.8%	Shares	Sole	2024-08-13
2024-03-31	$806,665	6,231	+7.6%	Shares	Sole	2024-05-15
2023-12-31	$558,522	5,792	+91.5%	Shares	Sole	2024-02-14
2023-09-30	$366,690	3,025	-6.0%	Shares	Sole	2023-11-13
2023-06-30	$368,410	3,217	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.